Davenport & CO LLC Dexcom Inc Transaction History

Davenport & CO LLC

$17.1 Billion
Q2 2025

A detailed history of Davenport & CO LLC transactions in Dexcom Inc stock. As of the latest transaction made, Davenport & CO LLC holds 69,943 shares of DXCM stock, worth $5.61 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

69,943

Previous 45,136 54.96%

Holding current value

$5.61 Million

Previous $3.08 Million 98.09%

% of portfolio

0.04%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 22, 2025	BUY	$59.83 - $87.57 $1.48 Million - $2.17 Million	24,807 Added 54.96%	69,943 $6.11 Million
Q1 2025 Apr 28, 2025	BUY	$67.74 - $90.75 $448,100 - $600,311	6,615 Added 17.17%	45,136 $3.08 Million
Q4 2024 Jan 24, 2025	BUY	$65.68 - $81.01 $57,338 - $70,721	873 Added 2.32%	38,521 $3 Million
Q3 2024 Oct 24, 2024	BUY	$64.0 - $116.06 $1.94 Million - $3.52 Million	30,370 Added 417.28%	37,648 $2.52 Million
Q2 2024 Aug 06, 2024	BUY	$110.31 - $140.45 $30,224 - $38,483	274 Added 3.91%	7,278 $825,000
Q1 2024 May 03, 2024	BUY	$114.22 - $140.1 $68,303 - $83,779	598 Added 9.33%	7,004 $971,000
Q4 2023 Jan 23, 2024	SELL	$75.49 - $124.16 $44,388 - $73,006	-588 Reduced 8.41%	6,406 $794,000
Q3 2023 Oct 17, 2023	SELL	$86.06 - $137.93 $8,261 - $13,241	-96 Reduced 1.35%	6,994 $652,000
Q2 2023 Jul 20, 2023	BUY	$112.47 - $130.98 $76,367 - $88,935	679 Added 10.59%	7,090 $911,000
Q1 2023 Apr 27, 2023	SELL	$104.0 - $122.92 $1.02 Million - $1.21 Million	-9,840 Reduced 60.55%	6,411 $744,000
Q4 2022 Jan 20, 2023	SELL	$84.98 - $122.67 $8,922 - $12,880	-105 Reduced 0.64%	16,251 $0
Q3 2022 Oct 11, 2022	BUY	$76.35 - $94.18 $272,798 - $336,505	3,573 Added 27.95%	16,356 $1.32 Million
Q2 2022 Jul 18, 2022	BUY	$67.99 - $132.89 $772,638 - $1.51 Million	11,364 Added 800.85%	12,783 $953,000
Q1 2022 May 02, 2022	BUY	$94.08 - $130.2 $3,386 - $4,687	36 Added 2.6%	1,419 $726,000
Q4 2021 Feb 10, 2022	BUY	$129.87 - $162.82 $3,376 - $4,233	26 Added 1.92%	1,383 $743,000
Q3 2021 Oct 14, 2021	BUY	$106.71 - $143.18 $24,543 - $32,931	230 Added 20.41%	1,357 $742,000
Q2 2021 Jul 28, 2021	BUY	$80.99 - $107.93 $45,516 - $60,656	562 Added 99.47%	1,127 $481,000
Q1 2021 Apr 28, 2021	SELL	$84.79 - $104.74 $932 - $1,152	-11 Reduced 1.91%	565 $203,000
Q4 2020 Jan 13, 2021	BUY	$78.0 - $104.5 $3,588 - $4,807	46 Added 8.68%	576 $213,000
Q3 2020 Oct 15, 2020	BUY	$95.51 - $112.95 $477 - $564	5 Added 0.95%	530 $218,000
Q2 2020 Jul 28, 2020	BUY	$62.68 - $105.34 $32,907 - $55,303	525 New	525 $213,000

Others Institutions Holding DXCM

# of Institutions

1,104

Shares Held

375M

Call Options Held

5.63M

Put Options Held

4.47M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account